» Articles » PMID: 35541809

Resonant Waveguide Grating Based Assays for Colloidal Aggregate Detection and Promiscuity Characterization in Natural Products

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 11
PMID 35541809
Authors
Affiliations
Soon will be listed here.
Abstract

Small molecules, including natural compounds, in aqueous buffer that self-associate into colloidal aggregates is the main cause of false results in the early stage of drug discovery. Here we reported resonant waveguide grating (RWG) based assays to identify natural compound aggregation and characterize its influence on membrane receptors in living cells. We first applied a cell-free aggregation assay to determine compound critical aggregation concentration (CAC) values. Then we characterized the aggregators' influence on membrane receptors using three types of dynamic mass redistribution (DMR) assays. Results showed that colloidal aggregates may cause false activity in DMR desensitization assays; some of the false activities can be implied by the large response in DMR agonism assays and can further be identified by DMR antagonism assays. Furthermore, the aggregation mechanism was confirmed by addition of 0.025% tween-80, with cell signals attenuated and potency decreased. Finally, these observations were used for aggregate examination and promiscuity investigation of a traditional herbal medicine, , which ultimately led to the revealing of the true target and reduced the risk of a bioactivity tracking process at the very first stage. This study highlights that the RWG based assays can be used as practical tools to distinguish between real and false hits to provide reliable results in the early stage of drug discovery.

Citing Articles

Label-free biomolecular and cellular methods in small molecule epigallocatechin-gallate research.

Peter B, Szekacs I, Horvath R Heliyon. 2024; 10(3):e25603.

PMID: 38371993 PMC: 10873674. DOI: 10.1016/j.heliyon.2024.e25603.


Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure-Activity Relationship and Inhibition Profiles.

Wang P, Hou T, Xu F, Luo F, Zhou H, Liu F Int J Mol Sci. 2022; 23(18).

PMID: 36142671 PMC: 9504748. DOI: 10.3390/ijms231810747.


Natural Compounds as Target Biomolecules in Cellular Adhesion and Migration: From Biomolecular Stimulation to Label-Free Discovery and Bioactivity-Based Isolation.

Peter B, Boldizsar I, Kovacs G, Erdei A, Bajtay Z, Voros A Biomedicines. 2021; 9(12).

PMID: 34944597 PMC: 8698624. DOI: 10.3390/biomedicines9121781.

References
1.
McGovern S, Helfand B, Feng B, Shoichet B . A specific mechanism of nonspecific inhibition. J Med Chem. 2003; 46(20):4265-72. DOI: 10.1021/jm030266r. View

2.
Seidler J, McGovern S, Doman T, Shoichet B . Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem. 2003; 46(21):4477-86. DOI: 10.1021/jm030191r. View

3.
Baell J . Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). J Nat Prod. 2016; 79(3):616-28. DOI: 10.1021/acs.jnatprod.5b00947. View

4.
Shapiro A, Walkup G, Keating T . Correction for interference by test samples in high-throughput assays. J Biomol Screen. 2009; 14(8):1008-16. DOI: 10.1177/1087057109341768. View

5.
Zhou S, Chan E, Duan W, Huang M, Chen Y . Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev. 2005; 37(1):41-213. DOI: 10.1081/dmr-200028812. View